Skip to search.
 TSX Up 0.04% TSX Ventures Up 0.41%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
3.57 Down 0.54(13.05%) Jul 28, 4:00PM EDT
Prev Close:4.10
Open:3.78
Bid:3.55 x 300
Ask:3.94 x 2000
1y Target Est:10.83
Beta:1.70863
Next Earnings Date: 2-Aug-16RGLS Earnings announcement
Day's Range:3.54 - 3.93
52wk Range:2.44 - 10.60
Volume:732,886
Avg Vol (3m):911,089
Market Cap:188.16M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.54
Quarterly EPS Est (Jun-16) :-0.38
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback